GI Flashcards

1
Q

Cimetidine, Ranitidine, Famotidine, Nizatidine (MOA)

A

Reversible H2 receptor blockers -> decreased secretion by parietal cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Cimetidine, Ranitidine, Famotidine, Nizatidine (CU)

A

Peptic ulcer, gastritis, mild esophageal reflux

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Cimetidine, Ranitidine, Famotidine, Nizatidine (T)

A

Cimetidine is a potent inhibitor of city P450 (multiple drug interactions) it also has antiangregenic effects (prolactin release, gynocomastia, impotence, decreased libido in males); can cross BBB (confusion, dizziness, HA) and placenta. Both cimetidine and ranitidine decrease renal excretion of creatinine. Other H2 blockers are relatively free of these effects.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Omeprazole. Lansoprazole (MOA)

A

Irreversibly inhibit H+/K+ ATPase in stoamch parietal cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Omeprazole. Lansoprazole (CU)

A

Peptic ulcer, gastritis, esophageal reflux, Z-E syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Omeprazole. Lansoprazole (T)

A

Increased risk of C. diff infection, pneumonia. Hip fractures, decreased serum Mg with long term use.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Bismuth, sucralfate (MOA)

A

Bind to ulcer base, providing physical protection and allowing bicarb secretion to reestablish pH gradient in the mucous layer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Bismuth, sucralfate (CU)

A

Increased ulcer healing, travelers’ diarrhea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Misoprostol (MOA)

A

PGE1 analog. Increased production and secretion of gastric mucous barrier, decreased acid production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Misoprostol (CU)

A

Prevention of NSAID-induced peptic ulcer; maintenance of a PDA. Also used to induce labor (ripens cervix)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Octreotide (MOA)

A

Long-acting somatostatin analog

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Octreotide (CU)

A

Acute variceal bleeds, acromegaly, VIPoma, and carcinoid tumors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Octreotide (T)

A

Nausea, cramps, steatorrhea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Misoprostol (T)

A

Diarrhea, Contraindicated in women of childbearing potential (abortifacient).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Aluminum hydroxide

A

Antacid. Hypokalemia. Constipation and hypophosphatemia: proximal muscle weakness, osteodystrophy, seizures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Calcium carbonate

A

Antacid. Hypokalemia. Hypercalcemia, rebound acid increase. Can chelate and decrease effectiveness of other drugs (tetracyclines)

17
Q

Magnesium hydroxide

A

Antacid. Osmotic laxative. Hypokalemia. Diarrhea, hyporeflexia, hypotension, cardiac arrest.

18
Q

Magnesium citrate (MOA)

A

Osmotic laxative. Provide osmotic load to draw water out.

19
Q

Magnesium citrate (CU)

A

Constipation

20
Q

Magnesium citrate (T)

A

Diarrhea, dehydration, may be abused by bulimics.

21
Q

Polyethylene glycol (MOA)

A

Osmotic laxative. Provide osmotic load to draw water out.

22
Q

Polyethylene glycol (CU)

A

Constipation

23
Q

Polyethylene glycol (T)

A

Diarrhea, dehydration, may be abused by bulimics.

24
Q

Lactulose (MOA)

A

Osmotic laxative. Provide osmotic load to draw water out. Treats hepatic encephalopathy since gut flora degrades it into metabolites (lactic acid and acetic acid) that promotes nitrogen excretion as NH4+

25
Q

Lactulose (CU)

A

Constipation. Hepatic encephalopathy

26
Q

Lactulose (T)

A

Diarrhea, dehydration, may be abused by bulimics.

27
Q

Sulfasalazine (MOA)

A

A combination of sulfapyridine (antibacterial) and 5-aminosalicylic acid (anti-inflammatory). Activated by colonic bacteria.

28
Q

Sulfasalazine (CU)

A

IBD

29
Q

Sulfasalazine (T)

A

Malaise, nausea, sulfonamide toxicity, reversible oligospermia.

30
Q

Ondansetron (MOA)

A

5-HT3 antagonist; decreases vagal stimulation. Powerful central acting antiemetic.

31
Q

Ondansetron (CU)

A

Control vomiting postop and in pts undergoing chemo

32
Q

Ondansetron (T)

A

HA, constipation

33
Q

Metoclopramide (MOA)

A

D2 receptor antagonist. Increases resting tone, contractility, LES tone, motility. Does not influence colon transport time.

34
Q

Metoclopramide (CU)

A

Diabetic and post-op gastroparesis (gastric motor failure). Antiemetic.

35
Q

Metoclopramide (T)

A

Increased parkinsonian effects. Restlessness, drowsiness, fatigue, depression, nausea, diarrhea. Drug interaction with Digoxin and diabetic agents. Contraindicated in pots with small bowel obstruction or Parkinson ds (D1-receptor blockade)